Reliq Health Technologies: Remote Patient Monitoring

February 16, 2021

Innovative solutions for community-based healthcare

Reliq Health Technologies is a rapidly growing technology company. They're focused on developing innovative remote patient monitoring, care collaboration and telemedicine solutions for community-based healthcare. Reliq Health's solutions are setting the standard for community care.

The company's virtual care platform uses a high tech, low touch approach to provide high-quality healthcare in the community setting, while reducing the cost of care delivery. iUGO CARE is a powerful platform for care coordination and home healthcare that integrates wearables, sensors, voice technology with intuitive mobile apps and desktop software for patients, families, clinicians, and healthcare administrators.

Furthermore, iUGO CARE allows patients with complex care needs to receive high-quality healthcare at home; improving health outcomes, enhancing the quality of life for patients and families, and reducing the cost of care delivery.

The platform also provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Moreover, these subscription services ensure recurring revenue, and a significant slice of the massive US community healthcare market.

Reliq's target markets are the following:

  • Post-discharge care solutions for hospitals, home care agencies, family practices, and collaborative community care teams, long-term care
  • Long-Term Care - connected care systems for assisted living facilities and nursing homes to support care providers and facilitate communication with patients’ families.
  • Big Data - anonymized patient-level data delivers real-world insights into chronic disease treatment and outcomes to support evidence-based care.

For more information on Reliq Health Technologies Inc. (TSX.V: RHT, OTCQB: RQHTF) please fill out the form below.

You might also like

Healthcare
Lexaria Bioscience: Transforming GLP-1 Drug Delivery for a Growing Market

Lexaria Bioscience is advancing GLP-1 drug delivery, aiming to improve effectiveness and reduce side effects for this fast-growing market.

Healthcare
Sernova: Advancing the Future of Diabetes Treatment

Sernova's clinical trials for type 1 diabetes have led to multiple patients achieving insulin independence and stable long-term blood sugar levels.

Content Broadcast on: BNN Bloomberg, CNBC, Bloomberg, FOX Business News, BIZTV, Reuters, The Globe and Mail, YouTube and more!